School of Medicine


Showing 21-40 of 165 Results

  • Vivek Charu

    Vivek Charu

    Assistant Professor of Pathology and of Medicine (Quantitative Sciences)

    BioI am a physician and a biostatistician. My clinical expertise is in the diagnosis of non-neoplastic kidney and liver disease (including transplantation). My research interests center on the design of observational studies and clinical trials, the analysis of observational data, and causal inference.

  • Greg Charville, MD, PhD

    Greg Charville, MD, PhD

    Assistant Professor of Pathology

    BioDr. Charville has a special interest in the diagnosis of rare tumors that derive from bone and soft tissues, including muscle, fat, blood vessels, cartilage, and other connective tissues. He also specializes in the classification and study of diseases related to the gastrointestinal and hepatopancreatobiliary systems.

    Dr. Charville particularly enjoys working alongside Stanford's excellent physicians-in-training to classify the most diagnostically challenging cases in collaboration with pathologists from around the world, bringing to bear cutting-edge techniques for comprehensive histologic and molecular characterization in each case. This experience serves as the inspiration for laboratory-based investigation of the molecular basis of human disease, focusing on genetic and epigenetic mechanisms of neoplasia.

  • Michael Cleary

    Michael Cleary

    Lindhard Family Professor of Pediatric Cancer Biology and Professor of Pathology

    Current Research and Scholarly InterestsThe role of oncoproteins in cancer and development; molecular and cellular biology of hematologic malignancies; targeted molecular therapies of cancer.

  • Maria Inmaculada Cobos Sillero

    Maria Inmaculada Cobos Sillero

    Assistant Professor of Pathology

    Current Research and Scholarly InterestsOur lab uses cellular and molecular methods, single-cell technology, and quantitative histology to study human neurodegenerative diseases. Current projects include:

    - Using single-cell RNA-sequencing to understand selective vulnerability and disease progression in human Alzheimer’s disease brain

    - Investigating mechanisms of tau-related neurodegeneration in human brain

    - Studying the neocortical and limbic systems in Diffuse Lewy Body Disease (DLBD) at the single cell level

  • Le Cong

    Le Cong

    Assistant Professor of Pathology (Pathology Research) and of Genetics

    BioDr. Cong's research group at the Department of Pathology and Department of Genetics is developing technology for genome editing and single-cell genomics, using computational approaches inspired by data science. His group has a focus on using these tools to study immunological and infectious diseases. His work has led to one of the first FDA-approved clinical trials employing viral delivery of CRISPR/Cas9 gene-editing for in vivo gene therapy. More recently, his group has invited high-efficiency tools for large-scale genome engineering based on novel microbial proteins, and developed single-cell analysis approach with applications in cancer biology and immunology. Dr. Cong is a recipient of the NIH/NHGRI Genomic Innovator Award, a Baxter Foundation Faculty Scholar, and has been selected by Clarivate Web of Science as a Highly Cited Researcher.

  • Joanne Cornbleet

    Joanne Cornbleet

    Associate Professor of Pathology at the Stanford University Medical Center, Emerita

    Current Research and Scholarly InterestsAs medical director of the Hematology Laboratory, my main focus is service work, including laboratory administration, bone marrow pathology, and flow cytometry interpretation. Publications arise primarily from development or evaluation of laboratory methods or collections of unusual patient cases.

  • Helio Costa

    Helio Costa

    Adjunct Clinical Assistant Professor, Pathology

    BioHelio Costa, PhD, is a medical geneticist with expertise in oncology, medical genetics and genomics, computational biology, data science, software engineering, and product development. He is passionate about leveraging his interdisciplinary skillset to build and develop commercial-grade cancer diagnostic products and medical software that aid in patient care and clinical decision support. Currently he is Medical Director of Oncology at Natera, and an Adjunct Clinical Assistant Professor in the Department of Pathology at Stanford Medical School.

    Dr. Costa's research focuses on developing and implementing new medical diagnostic genetic tests and software for use in patient care. His research group developed DNA and RNA cancer diagnostic tests currently in use at Stanford Health Care as well as developing clinical algorithms using large-scale clinical laboratory datasets and patient electronic medical records to predict patient outcomes and aid in therapeutic clinical decision support. Additionally, Dr. Costa served as a co-Investigator in the NIH Clinical Genome Resource (ClinGen) Consortium, and led the engineering and product management teams developing FDA-recognized medical software applications used by healthcare providers, researchers, and biotechnology companies to define the clinical relevance of genes and pathogenicity of mutations identified in patients.

    Dr. Costa is the founding director of the Stanford Clinical Data Science Fellowship where post-doctoral fellows engage in interdisciplinary clinical research and embed in health care workflows learning, building and deploying real-world health data solutions in the Stanford Health Care system. He is currently an Attending Medical Geneticist for the Molecular Genetic Pathology Laboratory at Stanford Health Care where he previously served as an Assistant Lab Director.

    Dr. Costa received his BS in Genetics from University of California at Davis, his PhD in Genetics from Stanford University School of Medicine, and his ABMGG Clinical Molecular Genetics and Genomics fellowship training from Stanford University School of Medicine.

  • Tina Cowan

    Tina Cowan

    Professor of Pathology (Clinical) and, by courtesy, of Pediatrics (Genetics)

    Current Research and Scholarly Interestsscreening and diagnosis of patients with inborn errors of metabolism, including newborn screening, development of new testing methods and genotype/phenotype correlations.

  • Gerald Crabtree

    Gerald Crabtree

    David Korn, MD, Professor of Pathology and Professor of Developmental Biology
    On Leave from 10/01/2021 To 09/30/2022

    Current Research and Scholarly InterestsChromatin regulation and its roles in human cancer and the development of the nervous system. Engineering new methods for studying and controlling chromatin and epigenetic regulation in living cells.

  • John W. Day, MD, PhD

    John W. Day, MD, PhD

    Professor of Neurology, of Pediatrics (Genetics) and, by courtesy, of Pathology

    Current Research and Scholarly InterestsOur Neuromuscular Division coordinates a comprehensive effort to conquer peripheral nerve and muscle disorders, including the muscular dystrophies, motor neuron disorders, neuromuscular junction abnormalities, and peripheral neuropathies. With patients and families foremost in mind, we have had success defining and combating these diseases, with research focused on identifying genetic causes, developing novel treatment, and maximizing patient function by optimizing current management.

  • Dylan Dodd

    Dylan Dodd

    Assistant Professor of Pathology and of Microbiology and Immunology

    Current Research and Scholarly InterestsHarnessing the gut microbiome to treat human disease.

  • Lawrence Eng

    Lawrence Eng

    Professor (Research) of Pathology, Emeritus

    Current Research and Scholarly InterestsAstrocytes make up a substantial proportion of the central nervous system (CNS) and participate in a variety of important physiologic and pathologic processes. They are characterized by vigorous response to diverse neurologic insults.

  • Edgar Engleman

    Edgar Engleman

    Professor of Pathology and of Medicine (Immunology and Rheumatology)

    Current Research and Scholarly InterestsDendritic cells, macrophages, NK cells and T cells; functional proteins and genes; immunotherapeutic approaches to cancer, autoimmune disease, neurodegenerative disease and metabolic disease.

  • Dean W. Felsher

    Dean W. Felsher

    Professor of Medicine (Oncology) and of Pathology

    Current Research and Scholarly InterestsMy laboratory studies the molecular basis of cancer with a focus on understanding when cancer can be reversed through targeted oncogene inactivation.

  • Marcelo Fernandez Vina

    Marcelo Fernandez Vina

    Professor of Pathology (Research)

    BioMarcelo Fernández-Viña, Ph.D., D (ABHI) is a Professor for the Department of Pathology at Stanford University Medical School and serves as Director of the Histocompatibility, Immunogenetics and Disease Profiling Laboratory at this institution. He has been working in the fields of Histocompatibility and Immunogenetics since 1982. He earned a degree in Biochemistry from the School of Basic Sciences in Rosario, Argentina, and his Ph.D. in Internal Medicine from the University of Buenos Aires Medical School in Argentina. Previously he held a position as a Professor in the Department of Laboratory Medicine at the University of Texas M.D. Anderson Cancer Center in Houston. He has more than 180 peer reviewed publications, many of them focusing on HLA variation in multiple world populations, identifying susceptibility and resistance factors for diseases and in the impact of HLA mismatches in allogeneic transplantation; and 59 book chapters. He served as expert Consultant for Donor Searches for NMDP and as President Elect, President and Past President of the American Society for Histocompatibility and Immunogenetics. He served as a member of the Board of Directors and the Executive Committee for the United Network for Organ Sharing. He served as Co-Chair of the Immunobiology Committee of the CIBMTR; He also served as a member of the HHS Advisory Council on Blood Stem Cell Transplantation (ACBSCT).He serves as HLA Expert Consultant for the NMDP for the HRSA contract and is a member of the Histocompatibility Advisory Group for NMDP. He is Councilor of the International Histocompatibility Workshop and a member of the WHO Nomenclature Committee for Factors of the HLA System and was Chairman of the (17th) International HLA & Immunogenetics Workshop, and current President of the International HLA & Immunogenetics Workshop. He is Section Editor of Human Immunology and an Advisory Board Member of the International Journal of Immunogenetics and Bone Marrow Transplantation.

  • Sebastian Fernandez-Pol

    Sebastian Fernandez-Pol

    Clinical Assistant Professor, Pathology

    BioDr. Sebastian Fernandez-Pol is an academic hematopathologist with fellowship training in hematopathology and dermatopathology. He has a particular interest in improving diagnostic accuracy for cutaneous lymphoproliferative disorders. Dr. Fernandez-Pol received his B.A. in chemistry with a concentration in biochemistry from the Washington University in St. Louis in 2003, his MD and PhD from Northwestern University in 2013, and completed his anatomic pathology and clinical pathology residency, hematopathology fellowship, and dermatopathology fellowship at Stanford University in 2019.